| 5fC | 5-formylcytosine |
| ALK | anaplastic lymphoma kinase gene |
| BRAF | human gene that encodes a protein called B-Raf |
| CA-125 | cancer/ carcinoma antigen 125, or carbohydrate antigen 125 |
| CEA | carcinoembryonic antigen |
| cfDNA | cell-free DNA |
| cfRNA | cell-free RNA |
| CHIP | clonal hematopoiesis of indeterminate potential |
| CI | confidence interval |
| CpG | dinucleotide DNA where a cytosine (C) nucleotide is followed by a guanine (G) nucleotide |
| CRC | colorectal cancer |
| CRPC | castrate-resistant prostate cancer |
| CSC | cancer stem cell |
| CSF | cerebrospinal fluid |
| CTC | circulating tumor cell |
| ctDNA | circulating tumor-derived DNA |
| DELFI | DNA evaluation of fragments for early interception |
| DFS | disease-free survival |
| DNA | deoxyribonucleic acid |
| EC | endometrial cancer |
| EGFR | epidermal growth factor receptor |
| ER | estrogen receptor |
| ESMO | European Society for Medical Oncology |
| ET | end of treatment |
| EV | extracellular vesicle |
| FDA | Food and Drug Administration |
| FTV | functional tumor volume |
| HER2 | human epidermal growth factor receptor 2 |
| HR | hazard ratio |
| ICB | immune checkpoint blockade |
| KRAS | “Kirsten rat sarcoma virus” is a gene that provides instructions for making a protein called K-Ras |
| LB | liquid biopsy |
| mAb | monoclonal antibody |
| MRD | minimal residual disease |
| mRNA | messenger RNA |
| MSI | microsatellite instability |
| MT | middle of thetherapy |
| mtDNA | mitochondrial DNA |
| NAT | neoadjuvant therapy |
| NCCN | National Comprehensive Cancer Network |
| NCDB | National Cancer Database |
| NGS | next-generation sequencing |
| NSCLC | non-small-cell lung cancer |
| OC | ovarian cancer |
| OR | odds ratio |
| OS | overall survival |
| PCR | polymerase chain reaction |
| PFS | progression-free survival |
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| PSA | prostate-specific antigen |
| RFS | relapse-free survival |
| RNA | ribonucleic acid |
| RT | radiotherapy |
| SCLC | small cell lung cancer |
| TEP | tumor-educated platelets |
| TET | ten-eleven translocation enzyme |
| TKI | tyrosine kinase inhibitor |
| TMB | tumor mutational burden |
| TNBC | triple-negative breast cancer |
| TP53 | tumor protein p53 |
| VAF | variant allele frequency |